Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

Multiple sclerosis (MS) is an autoimmune disease characterized by demyelination and neuroinflammation, often accompanied by cognitive impairment. This study aims (1) to investigate the potential of glatiramer acetate (GA) as a therapy for preventing cognitive decline in patients with MS (pwMS) by mo...

Full description

Bibliographic Details
Main Authors: Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, Lara Nogueras, Cristina González-Mingot, Petya Valcheva, Pascual Torres, Jose Carlos Serrano, Silvia Peralta, Maria José Solana, Luis Brieva
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/4/459